tiprankstipranks
X4 Pharmaceuticals Inc (XFOR)
NASDAQ:XFOR

X4 Pharmaceuticals (XFOR) Cash flow

753 Followers

X4 Pharmaceuticals Cash Flow

XFOR's free cash flow for Q4 2023 was $-27.77M. For the 2023 fiscal year, XFOR's free cash flow was decreased by $-19.36M and operating cash flow was $-27.73M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -48.56M$ -96.50M$ -77.10M$ -70.91M$ -58.82M$ -48.05M
Investing Cash Flow
$ -9.99M$ -14.88M$ -103.00K$ -615.00K$ -1.36M$ 27.23M
Financing Cash Flow
$ 21.30M$ 88.52M$ 117.23M$ 74.25M$ 12.39M$ 140.66M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 232.57M$ 100.25M$ 123.03M$ 83.11M$ 80.70M$ 128.09M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 4.60M$ 4.60M$ 3.01M$ 2.91M$ 2.10M$ 1.28M
Issuance Of Capital Stock
$ -8.61M---$ 0.00$ 139.39M
Issuance Of Debt
$ 21.74M$ 20.44M$ -795.00K-$ 12.39M$ 9.85M
Repayment Of Debt
-$ -2.06M$ -795.00K-$ 0.00$ -9.37M
Free Cash Flow
$ -27.77M$ -96.56M$ -77.20M$ -71.52M$ -60.18M$ -48.23M
Domestic Sales
------
Foreign Sales
------
Currency in USD

X4 Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis